MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board to consider approval of unaudited financial results

25 Oct 2013 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2013, to consider approval of unaudited financial results for the quarter ended September 30, 2013 (Q3).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1852.50
Dr. Reddys Labs. 1146.30
Cipla 1360.10
Lupin 2047.00
Zydus Lifesciences 1108.50
View more..